Ryan Cross
@scienceboss.bsky.social
Senior Science Correspondent at Endpoints News. Reach out privately on Signal: RyanCross.25
And you can read about about the incredible 6-month race to make Baby KJ's custom CRISPR therapy in my deep dive that I wrote for Endpoints back in May: endpoints.news/philadelphia...
The inside story of the six-month sprint to create the first custom CRISPR therapy for one infant’s rare disease
Two researchers have been working to rapidly design custom CRISPR treatments for rare diseases that profit-driven drug companies have left behind. But one child's dire condition provided an opportunit...
endpoints.news
October 31, 2025 at 12:59 PM
And you can read about about the incredible 6-month race to make Baby KJ's custom CRISPR therapy in my deep dive that I wrote for Endpoints back in May: endpoints.news/philadelphia...
Earlier this month I interviewed Kiran Musunuru about his plans for a Phase 1/2 trial that could turn Baby KJ’s one-off therapy into an approvable, repeatable procedure for making custom CRISPR therapies. We'll discuss the details on Post-Hoc Live today. endpoints.news/qa-scientist...
Q&A: The scientists behind Baby KJ’s custom CRISPR drug are planning a trial to help more children
Scientists led by Kiran Musunuru plan clinical trial for custom gene editing therapies, following success with
endpoints.news
October 31, 2025 at 12:59 PM
Earlier this month I interviewed Kiran Musunuru about his plans for a Phase 1/2 trial that could turn Baby KJ’s one-off therapy into an approvable, repeatable procedure for making custom CRISPR therapies. We'll discuss the details on Post-Hoc Live today. endpoints.news/qa-scientist...
Earlier this year I visited Bexorg to see its brain-in-a-bucket experiments in person. The approach raises many technical and ethical questions which I dug into in my profile of the startup in June. Read more here:
endpoints.news/rebooting-de...
endpoints.news/rebooting-de...
Exclusive: Rebooting dead human brains, a biotech startup seeks to reinvent early drug testing work
Startup Bexorg, led by Zvonimir Vrselja, keeps human brains alive to test drugs. Their BrainEx system sustains brain cells for 24 hours to improve drug development and reduce animal testing.
endpoints.news
October 15, 2025 at 1:25 PM
Earlier this year I visited Bexorg to see its brain-in-a-bucket experiments in person. The approach raises many technical and ethical questions which I dug into in my profile of the startup in June. Read more here:
endpoints.news/rebooting-de...
endpoints.news/rebooting-de...